Antimicrobial Stewardship Protocols
Clinical Pathways and Guidance
Guidelines for Initial Therapy for Common Pediatrics Infections (PDF)
Antibiotic Prophylaxis in ECMO Patients: Cannulation in Sterile Setting and Cannulation in Non-Sterile Setting
Appendicitis Antibiotic Selection Guideline
Drug-Susceptible Tuberculosis Therapy Guideline (PDF)
ENT Peri-Operative Antibiotic Prophylaxis Guidelines
Fever in Infants (8 to 21 days old) Pathway
Fever in Oncology Patients Pathway
Liver Transplant Post-Op Antimicrobial Selection and Duration
Neonatal and Young Infant (7-60 day) Urinary Tract Infection Pathway
NICU Late Onset Sepsis Algorithm
Palivizumab (Synagis®) Guideline
Pediatric Sepsis and Septic Shock Pathway
Prolonged Fever and Neutropenia Pathway
Skin and Soft Tissue Infections
Surgical Prophylaxis Guidelines: LPCH Surgical Prophylaxis Guideline and ASHP Surgical Prophylaxis Guideline
Antimicrobial Dosing and Monitoring
Antimicrobial Monitoring Guidelines
Amoxicillin-clavulanate (Augmentin®) Dosing Guide (PDF)
Azole Antifungal Therapeutic Drug Monitoring Guidance (PDF)
LPCH Blue Card – Antibiogram and Antimicrobial Dosing Quick Reference Card (PDF)
Pediatric Renal Antibiotic Dosing Recommendations (PDF)
Prolonged Infusion of Beta-Lactam Guidelines
Vancomycin per Pharmacy
- Vancomycin Guideline for Neonates and Children
- Vancomycin Guideline in Hemodialysis
- Initial Vancomycin Dosing Guideline for Surgical Patients up to 1 Week Post-op
- ASHP Vancomycin Therapeutic Monitoring Guidelines
Antibiotic Allergy
Antibiotic Desensitization Protocol
Antibiotic Graded Challenge Protocol
Allergy Clinical Decision Support Tool
– Antibiotic Allergy Clinical Decision Support Tool
– Antibiotic Allergy Tool – Rationale Document
– Antibiotic Allergy Tool Instructions Powerpoint (PPTX)
– Video Tutorial
Antimicrobial Restrictions
List of restricted antimicrobials at LPCH
Restricted antimicrobial approval process
COVID-19 Resources
COVID-19 Inpatient Treatment Algorithm
Evusheld Monoclonal Antibody against SARS CoV-2 for Pre-Exposure Prophylaxis
LPCH Therapies for High-Risk Nonhospitalized Patients with Mild to Moderate COVID-19
Multisystem Inflammatory Syndrome in Children (MIS-C) Pathway